Literature DB >> 6752194

Levels of antibody against Legionella pneumophila serotype 1 in healthy populations in five areas in New Zealand.

K A Bettelheim, R V Metcalfe, H Sillars.   

Abstract

Levels of antibody to Legionella pneumophila serogroup 1 in five areas of New Zealand were determined by indirect immunofluorescence. Both immunoglobulin G (IgG) and IgM levels were separately assessed. Of the 500 people studied, 2.8% had IgG titers of greater than or equal to 1:128 and 4.0% had IgM titers of greater than or equal to 1:128. Higher levels of IgG reactivity were noted in the southern part of New Zealand, but neither age nor sex appeared to be related to variations in antibody levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752194      PMCID: PMC272409          DOI: 10.1128/jcm.16.3.555-557.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Studies on antibody levels to Brucella abortus, Toxoplasma gondii and Leptospira serogroups in sera collected in five locations of the North Island of New Zealand.

Authors:  R V Metcalfe; K A Bettelheim; E B Densham; J Pearce; H Sillars; C Thorn
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1981

2.  Studies on antibody levels to Brucella abortus, Toxoplasma gondii and Leptospira serogroups in sera collected by the National Serum Bank during 1974-1976.

Authors:  R V Metcalfe; K A Bettelheim; M E Berry; K M Hobbs; A L Thompson; S P Cole
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-12

3.  Indirect immunofluorescence antibodies to Legionella pneumophila: frequency in a rural community.

Authors:  C M Helms; E D Renner; J P Viner; W J Hierholzer; L A Wintermeyer; W Johnson
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

4.  Legionnaires' disease: report of a sporadic case in New Zealand.

Authors:  M Wallace; D Macdonald
Journal:  N Z Med J       Date:  1980-06-25

5.  Legionnaires' disease in Wellington.

Authors:  P E Holst; A M Bilous; W J Frater; R V Metcalfe; K A Bettelheim
Journal:  N Z Med J       Date:  1980-05-14

6.  Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera.

Authors:  H W Wilkinson; D D Cruce; C V Broome
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

7.  Legionnaires' disease in a patient with polymyositis.

Authors:  K S McDonald; J L Faoagali; G B Tait; P W Moller
Journal:  N Z Med J       Date:  1980-06-25

8.  Classification of the Legionnaires' disease bacterium: Legionella pneumophila, genus novum, species nova, of the family Legionellaceae, familia nova.

Authors:  D J Brenner; A G Steigerwalt; J E McDade
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

9.  Antibodies to Legionella pneumophila serotype 1 among the healthy New Zealand population.

Authors:  K A Bettelheim; R V Metcalfe; H Sillars
Journal:  N Z Med J       Date:  1981-04-22
  9 in total
  5 in total

1.  Antibody levels to Mycoplasma pneumoniae in sera collected from healthy blood donors of Wellington, New Zealand, during 1976-80.

Authors:  J Pearce; K Bettleheim; R Metcalfe
Journal:  J Hyg (Lond)       Date:  1986-04

2.  Seroprevalence of Legionella in Shanxi Province, China.

Authors:  J Wang; M S Brown-Schlumpf; A Brown; X Z Xie
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

3.  Legionnaires disease in northern Italy.

Authors:  M C Re; B Baldassarri; G Furlini; P Coppolecchia; M P Landini
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

4.  A prevalence study of antibodies to Legionella spp. in geriatric institutions.

Authors:  I Boldur; M Ergaz; D Sompolinsky
Journal:  J Hyg (Lond)       Date:  1984-02

5.  Prevalence of antibodies in response to Legionella species, analysis of a healthy population from Jeollanam-do Province, Korea.

Authors:  Hae Kyung Lee; Mi Kyeong Woo; Yong In Ju; Soo Jin Baek; Hyeon Je Song; Jin Su Choi; Sun Seog Kweon; Doo Young Jeon; Yeon Ho Kang
Journal:  J Microbiol       Date:  2008-06-11       Impact factor: 3.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.